Ufp Technologies (UFPT) Gains from Sales and Divestitures (2012 - 2025)
Ufp Technologies (UFPT) reported Gains from Sales and Divestitures of $43296.0 for Q2 2025, down 14.4% on a YoY basis from $50582.0 in Q2 2024, and up 3.29% quarter-over-quarter from $41916.0 in Q1 2025.
Ufp Technologies (UFPT) Gains from Sales and Divestitures (2012 - 2025) Analysis & Trends
Ufp Technologies has reported Gains from Sales and Divestitures for 14 years, with the latest figure at $43296.0 in Q2 2025.
- For the quarter ending Q2 2025, Gains from Sales and Divestitures fell 14.4% year-over-year to $43296.0; the trailing twelve-month figure through Jun 2025 stood at $43296.0 (down 14.4% YoY), and the FY2024 full-year result was $50582.0, down 2.96% from the prior year.
- Gains from Sales and Divestitures for Q2 2025 stood at $43296.0, up from $41916.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $52126.0 in Q2 2023, with the low at $33892.0 in Q2 2021.
- Historically, Gains from Sales and Divestitures has averaged $46159.4 across 5 years, with a median of $49184.5 in 2022.
- Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures soared 46.27% — and 2025, when it decreased 14.4%.
- Ufp Technologies' Gains from Sales and Divestitures stood at $39214.0 in 2021, then increased by 26.42% to $49575.0 in 2022, then grew by 5.15% to $52126.0 in 2023, then decreased by 2.96% to $50582.0 in 2024, then declined by 14.4% to $43296.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $43296.0 (Q2 2025), $41916.0 (Q1 2025), and $50582.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.85 Bn | 1.83 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 43,296.00 |
| Jun 30, 2025 | 43,296.00 |
| Mar 31, 2025 | 41,916.00 |
| Mar 31, 2025 | 41,916.00 |
| Dec 31, 2024 | 50,582.00 |
| Dec 31, 2024 | 50,582.00 |
| Sep 30, 2024 | 50,582.00 |
| Sep 30, 2024 | 50,582.00 |
| Jun 30, 2024 | 50,582.00 |
| Jun 30, 2024 | 50,582.00 |
| Mar 31, 2024 | 48,794.00 |
| Mar 31, 2024 | 48,794.00 |
| Dec 31, 2023 | 52,126.00 |
| Dec 31, 2023 | 52,126.00 |
| Sep 30, 2023 | 52,126.00 |
| Sep 30, 2023 | 52,126.00 |
| Jun 30, 2023 | 52,126.00 |
| Jun 30, 2023 | 52,126.00 |
| Mar 31, 2023 | 48,244.00 |
| Mar 31, 2023 | 48,244.00 |